agilon health, inc. AGL

Updated: 10 Aug 2026

NYSE | Value-based healthcare platform

No signal published yet

We already track agilon health and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow agilon health free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Sector
Value-based healthcare platform
We're already tracking agilon health, inc. — here are the latest events we've registered

Recent News

  • On August 5, 2026, agilon health reported its second-quarter 2026 financial results with revenue of $1.495 billion and net income of $18 million. The company also raised its full-year 2026 revenue guidance to a range of $5.775 billion to $5.860 billion.

What Firelda Watch includes for agilon health, inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of agilon health, inc. will be delivered in the same format.

Want to follow agilon health, inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow agilon health free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

agilon health, inc. AGL
agilon health — follow and we'll monitor it
Follow agilon health free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.